The world’s leading manufacturer of speciality enzymes, has established its new Europe, Middle East and Africa (EMEA) hub at Milton Park.
Amano Enzymes, the Japanese biotechnology company – which uses its enzymes to boost the flavour, texture, colour, digestion and nutritional profiles of products in the booming plant-based ‘alternatives’ market – has occupied 5,682 sq ft of office and laboratory space to drive further company growth.
The move to Milton Park coincides with the company’s 30th anniversary in the UK, while 2023 marks its 40th anniversary in Europe, with plans underway for a significant recruitment drive across R&D, sales and customer service roles, which will see the company nearly double its workforce at the Park in the coming years.
Amano’s new premises at Milton Park, which oversees all operations across its EMEA sites, is undergoing a state-of-the-art fit-out. Once complete, the bespoke laboratory, comprising cutting-edge R&D equipment, will enable the company to further expand into strategic focus areas, such as plant-based food and drinks. In November, Amano will be showcasing its latest innovations featuring non-dairy drink options.
Milton Park offers the space to create bespoke laboratories in close proximity to Reading University’s Food and Nutritional Sciences hub, making it the ideal location for Amano Enzyme’s new EMEA base. Additionally, we were keen to find an innovative work environment with excellent public transport links. We’re thoroughly looking forward to growing our pipeline of work with the support of these new premises while at the same time networking with the many other pioneering biotechnology companies based at Milton Park.
Kazumi Washisaka, Managing Director at Amano Enzyme
To find out more about Amano Enzyme and its vacancies, visit: www.amano-enzyme.com